MiniMed Group, Inc. Common Stock (MMED)

Insulin pump maker with counted call centers. Read October 19, 2026 from the annual report for the period ending April 24, 2026, filed June 29, 2026. Ranked 30 of the 104 Healthcare companies read so far, by the share within reach now.

A diabetes device maker whose filing counts 8,000 employees with 1,300 in global call centers and 15% in research, so the call centers are read apart and the rest at medical equipment manufacturing.

The figures on this page come from the company's own annual report and from BLS staffing patterns for its industries, never from a roster. They are estimates with a stated method. Nothing here says what the company will do: within reach is not a forecast of jobs lost or of savings.

What follows from the reading

Share of working time within reach of AI, on the long-run pace at four in five: 23% now, 35% at the end of 2027, 40% at the end of 2028, 41% at the end of 2030. By the patterns, the work is about 41% desk work, 18% people work and 41% body work. These are the site's industry estimates weighted by the shares below: estimates with a stated method and range, not a forecast of what the company will do. By the same patterns, at the end of 2028 about 54% of the working time stays with people (conversation, in-person and hands-on work), 35% becomes checking a model's work and 8% could be handed over with lighter checks, from the industries' own figures, not the company's roles.

Headcount

8,000 employees as of April 24, 2026 (stated). Not stated: over 1,000 U.S. sales professionals are counted, but no count by country; the data service's 30% United States is revenue.

The filing: “We are supported by a dedicated, mission-focused global team of approximately 8,000 employees as of April 2026.”

The workforce as industry patterns

What the filing says about the workforce: Approximately 8,000 employees as of April 2026: over 2,800 commercial employees, over 1,300 of them in customer care and technology support call centers; over 1,000 U.S. sales professionals, field clinical representatives and territory managers; about 15% in innovation and research and development; two dedicated manufacturing facilities.

Companies read with the same leading pattern

Other companies whose largest staffing pattern is also Medical Equipment and Supplies Manufacturing, largest first, each read from its own annual report. Within reach now and at the end of 2028, long-run pace, four in five.

• Abbott Laboratories (ABT, 115,000 employees)18% now, 35% by 2028
• Becton, Dickinson and Company (BDX, 72,000 employees)19% now, 36% by 2028
• Boston Scientific Corporation (BSX, 59,000 employees)19% now, 42% by 2028
• Stryker Corporation (SYK, 56,000 employees)19% now, 39% by 2028
• Baxter International Inc. (BAX, 37,500 employees)19% now, 37% by 2028
• Align Technology, Inc. (ALGN, 20,290 employees)19% now, 36% by 2028
• Solventum Corporation (SOLV, 20,000 employees)20% now, 43% by 2028
• STERIS plc (STE, 17,937 employees)22% now, 39% by 2028

What the filing says about AI

13 sentences in the filing name AI. The filing describes an AI-enabled sales force powered by its MiniMed IQ software and third-party predictive tools, names AI and data science among the capabilities its industry requires, and says leaders develop teams with GenAI and productivity tools.

• “These statements include, among other things, MiniMed Group, Inc.'s ("MiniMed's" or the "Company's") statements about: our ability to drive long-term stockholder value; development and future launches of products and continued or future acceptance of products, therapies, and services in our segments; expected timing for completion of research studies relating to our products; integration of new...”
• “Our AI-enabled sales force is powered by software such as our proprietary MiniMed IQ, which provides real-time physician landscape insights nationwide and optimizes our account targeting strategy, and third-party tools, which optimize our lead generation strategies and enhance our sales forecasting with predictive analytics.”
• “To succeed in our industry requires capabilities across electrochemical, mechanical, electric, biomedical, and software engineering; algorithm development, AI, and data science; hardware design; and consumer-facing electronics experience.”
• “Leading our efforts are over 1,100 research and development professionals who bring a diversity of skills across electrochemistry, electronics, mechanical engineering, software, data science and AI, and consumer electronics and valuable experience in the diabetes space.”
• “Our team is composed of over 1,100 research and development professionals who bring a diversity of skills across electrochemistry, electronics, mechanical engineering, software, data science and AI, and consumer electronics and valuable experience in the diabetes space.”

Headcount by filing year

As reported in each year's annual report, with the filing. A year marked not read had no figure the reading could take from the report's text.

Limits of this reading

• The U.S. share is not stated.
• The counted customer care and technology support call centers are read apart at business support services; the research and development share stays inside the device pattern.

Source: the company's annual report on EDGAR, accession 0001628280-26-045915, the filing. Read by Claude Fable 5.1 under rubric version 1, by the method. A company can write to info@stratussc.com to have its reading checked against its filing.